A study published on October 29, 2026, by researchers at the MRC Laboratory of Medical Sciences and Imperial College London examined nearly 480,000 UK adults and revealed that chronic inflammation silently damages the heart long before symptoms appear. Higher inflammation levels, measured using glycoprotein acetyls (GlycA), were associated with thicker heart walls, smaller heart chambers, and a reduced ability to fill with blood. The research indicates that individuals in the top 20% for inflammation levels faced a 43% greater risk of heart attack and stroke compared to those in the bottom 20%. Furthermore, persistent inflammation serves as a critical bridge connecting socioeconomic disadvantage, psychological distress, smoking, and excess body fat to cardiovascular disease. Scientists identified that genetic susceptibility also plays a major role in determining how individuals respond to inflammatory triggers, meaning some people are naturally more resilient or vulnerable. Inflammatory proteins from the interleukin-1 and TNF families were highlighted as primary contributors to structural heart damage, pointing to future possibilities for targeted drug treatments. Practical applications of these findings include combining routine inflammation blood tests with genetic risk scores for earlier detection of vulnerable patients. Preventive measures such as smoking cessation, managing body weight, and addressing socioeconomic health disparities remain vital tools for reducing chronic inflammation and protecting long-term cardiovascular health.
